Though the overall debt is a concern; it is not out of control since most of it is working capital debt backed by good assets said Prabir Ghosh, wholetime director & group CFO, McNally Bharat.
Ind-Swift Laboratories full-year (April-March) net profit jumped 51% to Rs 87.62 crore on back of robust revenues from US and Europe and successful accredition of the company's manufacturing facilities by the Japanese and Korean regulatory authorities, the company said in a press release Thursday.